• Publications
  • Influence
Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite
One possible mechanism for the ultimate formation of R-138727 in vitro can be through formation of a sulfenic acid mediated by P450s followed possibly by a glutathione conjugation to a mixed disulfide and reduction of the disulfides to the active metabolite R- 138727.
Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
[2-(omega-phenylalkyl)phenoxy]alkylamines.II: Synthesis and selective serotonin-2 receptor binding.
(S)-2-[2- [2-(3-methoxyphenyl)ethyl]phenoxy]ethyl]-1-methylpyrrolidine, (S)-27, exhibited the most potent and selective affinity for 5-HT2 receptors and was effective in inhibiting 5- HT2-induced vasoconstriction in vitro and platelet aggregation both in vivo and ex vivo.
Cinnamylindoline derivatives: synthesis and factor Xa (FXa) inhibitory activities.
Some novel derivatives of cinnamylindoline derivatives showed potent FXa inhibitory activities and good selectivity over trypsin and exhibited potent anticoagulant activities in vitro.
[2-(O-Phenylalkyl)phenoxy]alkylamines III: Synthesis and selective serotonin-2 receptor binding (2).
A series of 12-(2-phenylethyl)phenoxy]ethylpyrrolidine derivatives were synthesized, and their affinity for serotonin-2 (5-HT2) and dopamine-2 (D2) receptors was examined. Among them, compound 17,